Amendment: SEC Form SCHEDULE 13D/A filed by S&W Seed Company
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 17)*
|
S&W SEED COMPANY (Name of Issuer) |
Common Stock, Par Value $0.001 (Title of Class of Securities) |
785135104 (CUSIP Number) |
TIMOTHY E. LADIN MFP INVESTORS LLC, 909 THIRD AVENUE, 33rd FLOOR NEW YORK, NY, 10022 (212) 752-7345 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
12/19/2024 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
CUSIP No. | 785135104 |
1 |
Name of reporting person
MFP PARTNERS LP | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
WC | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
993,187.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
42.1 % | ||||||||
14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
CUSIP No. | 785135104 |
1 |
Name of reporting person
MFP INVESTORS LLC | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
AF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
DELAWARE
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
993,187.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
42.1 % | ||||||||
14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
CUSIP No. | 785135104 |
1 |
Name of reporting person
Price Jennifer C. | ||||||||
2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
3 | SEC use only | ||||||||
4 |
Source of funds (See Instructions)
AF | ||||||||
5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
6 | Citizenship or place of organization
UNITED STATES
| ||||||||
Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
11 | Aggregate amount beneficially owned by each reporting person
993,187.00 | ||||||||
12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
13 | Percent of class represented by amount in Row (11)
42.1 % | ||||||||
14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
Item 1. | Security and Issuer | |
(a) | Title of Class of Securities:
Common Stock, Par Value $0.001 | |
(b) | Name of Issuer:
S&W SEED COMPANY | |
(c) | Address of Issuer's Principal Executive Offices:
2101 Ken Pratt Blvd, Suite 201, Longmont,
COLORADO
, 80501. | |
Item 1 Comment:
Explanatory Note
Pursuant to Rule 13d-2 promulgated under the Securities Exchange Act of 1934, as amended, this Amendment No. 17 to Schedule 13D (this "Amendment No. 17") amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission (the "SEC") by MFP Partners, L.P., MFP Investors LLC and Michael F. Price on June 1, 2015 (the "Original Schedule 13D") regarding the common stock, par value $0.001 per share (the "Common Stock"), of S&W Seed Company, a Nevada corporation (the "Company"), as amended by Amendment No. 1 on November 30, 2015 (the "Amendment No. 1"), as amended by Amendment No. 2 on March 1, 2016 (the "Amendment No. 2"), as amended by Amendment No. 3 on July 21, 2017 (the "Amendment No. 3), as amended by Amendment No. 4 on August 18, 2017 (the "Amendment No. 4"), as amended by Amendment No. 5 on August 18, 2017 (the "Amendment No. 5"), as amended by Amendment No. 6 on December 22, 2017 (the "Amendment No. 6"), as amended by Amendment No. 7 on June 18, 2018 (the "Amendment No. 7"), as amended by Amendment No. 8 on September 7, 2018 (the "Amendment No. 8"), as amended by Amendment No. 9 on November 21, 2018 (the "Amendment No. 9"), as amended by Amendment No. 10 on October 18, 2021 (the "Amendment No. 10"), as amended by Amendment No. 11 on February 28, 2022 (the "Amendment No. 11"), as amended by Amendment No. 12 on June 24, 2022 (the "Amendment No. 12"), as amended by Amendment No. 13 on October 28, 2022 (the "Amendment No. 13"), as amended by Amendment No. 14 on December 29, 2022 (the "Amendment No. 14"), as amended by Amendment No. 15 on March 24, 2023 (the "Amendment No. 15"), and as amended by Amendment No. 16 on November 20, 2024 (the "Amendment No. 16"). The Original Schedule 13D, as amended by the Amendment No. 1, the Amendment No. 2, the Amendment No. 3, the Amendment No. 4, the Amendment No. 5, the Amendment No. 6, the Amendment No. 7, the Amendment No. 8, the Amendment No. 9, the Amendment No. 10, the Amendment No. 11, the Amendment No. 12, the Amendment No. 13, the Amendment No. 14, the Amendment No. 15, the Amendment No. 16 and this Amendment No. 17 are together referred to herein as the "Schedule 13D".
Except as specifically amended by Amendment No. 1, the Amendment No. 2, the Amendment No. 3, the Amendment No. 4, the Amendment No. 5, the Amendment No. 6, the Amendment No. 7, the Amendment No. 8, the Amendment No. 9, the Amendment No. 10, the Amendment No. 11, the Amendment No. 12, the Amendment No. 13, the Amendment No. 14, the Amendment No. 15, the Amendment No. 16 and this Amendment No. 17, items in the Schedule 13D are unchanged. Capitalized terms used herein that are not defined herein have the meanings ascribed to them in the Schedule 13D.
| ||
Item 3. | Source and Amount of Funds or Other Consideration | |
Item 3 of the Schedule 13D is hereby amended and supplemented by adding the following at the end of Item 3:
"On December 19, 2024, the Company purchased 200,000 shares of Common Stock from MFP, pursuant to a Stock Purchase Agreement dated December 19, 2024 (the "2024 Stock Purchase Agreement"), by and between the Company and MFP, at a purchase price of $.15 per share for a total purchase price of $30,000.00. The Company purchased the shares of Common Stock using working capital.
The foregoing description of the 2024 Stock Purchase Agreement, and the transactions contemplated thereby do not purport to be complete and are qualified in their entirety by the full text of the Stock Purchase Agreement, which is attached as Exhibit 22 and incorporated herein by reference."
| ||
Item 4. | Purpose of Transaction | |
Item 4 of the Schedule 13D is hereby amended by adding the following as the penultimate paragraph of Item 4:
"Pursuant to the 2024 Stock Purchase Agreement, the Company granted MFP the right to designate one (1) individual (the "Observer"), who shall be a representative of MFP reasonably acceptable to the Company, to attend all meetings (whether in person, telephonic or otherwise) of the Company's Board of Directors (the "Board") and all committees of the Board in a non-voting, observer capacity. The foregoing description of the Observer rights granted to MFP in the 2024 Stock Purchase Agreement do not purport to be complete and is qualified in its entirety by the full text of the Stock Purchase Agreement, which is attached as Exhibit 22 and incorporated herein by reference."
| ||
Item 5. | Interest in Securities of the Issuer | |
(a) | Item 5 of the Schedule 13D is hereby amended by replacing Item 5(a) and (c) in its entirety with the following:
"(a) MFP directly owns 718,328 shares of Common Stock; 1,695 shares of Series B Preferred Stock, which is convertible at any time at the option of the holder into 106,817 shares of Common Stock (subject to obtaining approval of the issuance of such shares of Common Stock by the Company's stockholders, to the extent required under the Nasdaq Listing Rules); the Series B Warrant, exercisable for up to 29,440 shares of the Company's Common Stock; the warrant exercisable for up to 26,316 shares of the Company's Common Stock in connection with the MFP Loan Agreement; the warrant exercisable for up to 8,774 shares of the Company's Common Stock in connection with the First Amendment; and the warrant exercisable for up to 35,090 shares of the Company's Common Stock in connection with the Second Amendment; and the warrant exercisable for up to 68,422 shares of the Company's Common Stock in connection with the Third Amendment, representing approximately 42.1% of the outstanding shares of Common Stock (including the shares of Common Stock issuable upon conversion of MFP's shares of Series B Preferred Stock, and exercise of the warrants described above). The number of shares issuable upon conversion of the Series B Preferred Stock set forth above reflects the Company' election to pay the semi-annual installments of interest on the Series B Preferred Stock, due from March 31, 2022 through September 30, 2024, by adding a total of $986,838.46 to the Stated Value (calculated at a rate per share of 7% per annum on the then Stated Value as of each semi-annual interest payment date). The ownership percentage set forth above is based on 2,284,470 shares of Common Stock outstanding as set forth in the issuer's most recent Form 10-K, the shares of Common Stock issuable upon conversion of MFP's shares of Series B Preferred Stock and shares of Common Stock issuable upon exercise of the warrants described above, less 200,000 shares of Common Stock retired by the Company pursuant to the transaction reported herein."
| |
(c) | "(c) The information set forth in Item 3 of this Amendment No. 17 shall be incorporated herein by reference. Except as set forth in this Schedule 13D, there have been no other transactions by the Reporting Persons in the Issuer's Common Stock during the past sixty days."
| |
Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
The responses set forth in Item 3 hereof are incorporated by reference in their entirety. | ||
Item 7. | Material to be Filed as Exhibits. | |
Exhibit 1. Joint Filing Agreement, dated as of June 1, 2015, by and among MFP Partners, L.P., MFP Investors LLC and Michael F. Price*
Exhibit 2. Securities Purchase Agreement by and between S&W Seed Company and MFP Partners, L.P., dated as of December 30, 2014 (filed as Exhibit 4.1 of the Current Report on Form 8-K filed by S&W Seed Company on December 31, 2014 and incorporated herein by reference)*
Exhibit 3. Securities Purchase Agreement by and between S&W Seed Company and each of the investors named therein, dated as of December 30, 2014 (filed as Exhibit 10.1 of the Current Report on Form 8-K filed by S&W Seed Company on December 31, 2014 and incorporated herein by reference)*
Exhibit 4. Form of 8% Senior Secured Convertible Debenture (filed as Exhibit 10.2 of the Current Report on Form 8-K filed by S&W Seed Company on December 31, 2014 and incorporated herein by reference)*
Exhibit 5. Form of Common Stock Purchase Warrant (filed as Exhibit 10.3 of the Current Report on Form 8-K filed by S&W Seed Company on December 31, 2014 and incorporated herein by reference)*
Exhibit 6. Securities Purchase Agreement by and between S&W Seed Company and MFP Partners, L.P., dated as of November 23, 2015 (filed as Exhibit 10.1 of the Current Report on Form 8-K filed by S&W Seed Company on November 24, 2015 and incorporated herein by reference)*
Exhibit 7. Securities Purchase Agreement by and between S&W Seed Company and the Purchasers named therein, dated as of July 19, 2017 (filed as Exhibit 99.1 of the Current Report on Form 8-K filed by S&W Seed Company on July 19, 2017, and incorporated herein by reference)*
Exhibit 8. Stock Purchase Agreement by and between MFP Partners, L.P. and the Sellers named therein, dated as of August 15, 2017 (filed as Exhibit 8 of Amendment No. 4 to Schedule 13D filed by MFP Investors LLC on August 18, 2017 and incorporated herein by reference)*
Exhibit 9. Investment Agreement by and between S&W Seed Company and MFP Partners, L.P. (including the form of Registration Rights Agreement), dated as of October 3, 2017 (filed as Exhibit 99.1 of the Current Report on Form 8-K filed by S&W Seed Company on October 4, 2017 and incorporated herein by reference)*
Exhibit 10. Securities Purchase Agreement by and between S&W Seed Company and MFP Partners, L.P. (including the form of Registration Rights Agreement), dated as of September 5, 2018 (filed as Exhibit 10.1 of the Current Report on Form 8-K filed by S&W Seed Company on September 6, 2018, and incorporated herein by reference)*
Exhibit 11. Voting Agreement by and between S&W Seed Company, MFP Partners, L.P. and the other shareholders named therein, dated as of September 5, 2018 (filed as Exhibit 10.2 of the Current Report on Form 8-K filed by S&W Seed Company on September 6, 2018, and incorporated herein by reference)*
Exhibit 12. Securities Purchase Agreement by and between S&W Seed Company and the Purchasers named therein (including the form of Registration Rights Agreement), dated as of October 15, 2021 (filed as Exhibit 10.1 of the Current Report on Form 8-K filed by S&W Seed Company on October 18, 2021, and incorporated herein by reference)*
Exhibit 13. Securities Purchase Agreement, dated February 18, 2022, by and between S&W Seed Company and MFP Partners, L.P. (filed as Exhibit 10.1 of the Current Report on Form 8-K filed by S&W Seed Company on February 23, 2022, and incorporated herein by reference)*
Exhibit 14. Series B Redeemable Convertible Non-Voting Preferred Stock Certificate of Designation filed with the Nevada Secretary of State on February 18, 2022 (filed as Exhibit 3.1 of the Current Report on Form 8-K filed by S&W Seed Company on February 23, 2022, and incorporated herein by reference)*
Exhibit 15. Form of Warrant issued to MFP on February 18, 2022 (filed as Exhibit 4.1 of the Current Report on Form 8-K filed by S&W Seed Company on February 23, 2022, and incorporated herein by reference)*
Exhibit 16. Registration Rights Agreement, dated February 18, 2022, by and between S&W Seed Company and MFP Partners, L.P. (filed as Exhibit 10.2 of the Current Report on Form 8-K filed by S&W Seed Company on February 23, 2022, and incorporated herein by reference)*
Exhibit 17. Joint Filing Agreement, dated as of June 24, 2022, by and among MFP Partners, L.P., MFP Investors LLC and Jennifer Cook Price*
Exhibit 18. Form of Common Stock Purchase Warrant issued to MFP Partners, L.P. on September 22, 2022*
Exhibit 19. Form of Common Stock Purchase Warrant issued to MFP Partners, L.P. on October 28, 2022*
Exhibit 20. Form of Common Stock Purchase Warrant issued to MFP Partners, L.P. on December 22, 2022*
Exhibit 21 .Form of Common Stock Purchase Warrant issued to MFP Partners, L.P. on March 22, 2023*
Exhibit 22. Stock Purchase Agreement by and between S&W Seed Company and MFP Partners, L.P., dated as of December 19, 2024
* Filed previously
|
SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|